Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark L. Baum currently holds 2,996,130 shares of HARROW HEALTH, INC. (HROW), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark L. Baum has been a net buyer of HROW stock. They have purchased $1.3M and sold $430.0K worth of shares.
Mark L. Baum's most recent insider trade was on May 14, 2026, when they purchased 10,000 shares at $30.20 per share.
Mark L. Baum serves as Executive at HARROW HEALTH, INC. (HROW). They have executed 54 insider transactions totaling $1.7M over their tenure at the company.
Mark L. Baum holds the position of Executive at HARROW HEALTH, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Mark L. Baum has shown a buying trading pattern, with $1.3M in total purchases and $430.0K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Mark L. Baum was on Jul 21, 2025, when they sold $11.6M worth of HROW shares. This transaction involved 313,338 shares at $37.08 per share.
Mark L. Baum currently owns 2,996,130 shares of HARROW HEALTH, INC. (HROW), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark L. Baum's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark L. Baum has 54 Form 4 filings on record as an insider at HARROW HEALTH, INC..
Set alerts for Mark L. Baum and 40,000+ other insiders.